ANTX EV/EBITDA
-0.06
+0.01+14.29%
Tue, 21 Jan 2025 23:07:15 GMT
Summary:
As of January 22, 2025, ANTX EV/EBITDA is -0.06, with a rise of +0.01 (+14.29%) during the most recent trading day. Over the past year, it has increased by +7.82 (+99.24%). ANTX EV/EBITDA is now -200.00% below its all-time high of 0.06.ANTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANTX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +14.3% |
| 1 m1 month | 0.0% |
| 3 m3 months | -400.0% |
| 6 m6 months | +92.6% |
| ytdytd | +50.0% |
| 1 y1 year | +99.2% |
| 5 y5 years | - |
ANTX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -0.05 | -20.0% | -0.15 | +60.0% |
| 3 m | 3-month | 0.06 | -200.0% | -0.23 | +73.9% |
| 6 m | 6-month | 0.06 | -200.0% | -0.81 | +92.6% |
| 1 y | 1-year | 0.06 | -200.0% | -8.74 | +99.3% |
| 3 y | 3-year | 0.06 | -200.0% | -12.82 | +99.5% |
| 5 y | 5-year | 0.06 | -200.0% | -12.82 | +99.5% |
| alltime | all time | 0.06 | -200.0% | -12.82 | +99.5% |
AN2 Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.06(-50.0%) |
| 2024 | -0.12(-98.6%) |
| Date | Value |
|---|---|
| 2023 | -8.70(+133.2%) |
| 2022 | -3.73 |
FAQ
- What is AN2 Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for AN2 Therapeutics?
- What is ANTX EV/EBITDA year-to-date change?
- What is AN2 Therapeutics EV/EBITDA year-on-year change?
What is AN2 Therapeutics EV/EBITDA?
The current EV/EBITDA of ANTX is -0.06
What is the all time high EV/EBITDA for AN2 Therapeutics?
AN2 Therapeutics all-time high EV/EBITDA is 0.06
What is ANTX EV/EBITDA year-to-date change?
AN2 Therapeutics EV/EBITDA has changed by +0.06 (+50.00%) since the beginning of the year
What is AN2 Therapeutics EV/EBITDA year-on-year change?
Over the past year, ANTX EV/EBITDA has changed by +7.82 (+99.24%)